Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Pilgrim, Thomas ^a   Rothenbühler, Martina ^b   Kalesan, Bindu ^b   Pulver, Cédric ^a   Stefanini, Giulio G ^a   Zanchin, Thomas ^a   Räber, Lorenz ^a   Stortecky, Stefan ^a   Jung, Simon ^c   Mattle, Heinrich ^c   Moschovitis, Aris ^a   Wenaweser, Peter ^a   Meier, Bernhard ^a   Gsponer, Thomas ^b   Windecker, Stephan ^a   Jüni, Peter ^b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIA; KIDNEY DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; TREATMENT OUTCOME; ADVERSE EFFECTS; COMPLICATION; FOLLOW UP; MORTALITY; PATHOLOGY; PROGNOSIS; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

AGED; ANEMIA; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84916942187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114846     Document Type: Article

References (19)

1. McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, et al. (2004) Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 110:271-277.
2. Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK (2004) Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44:541-546.
3. Nikolsky E, Mehran R, Aymong ED, Mintz GS, Lansky AJ, et al. (2004) Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 94:1023-1027.
4. Reinecke H, Trey T, Wellmann J, Heidrich J, Fobker M, et al. (2003) Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24:2142-2150.
5. Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, et al. (2003) Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92:930-935.
6. Bassand J-P, Afzal R, Eikelboom J, Wallentin L, Peters R, et al. (2010) Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J 31:50-58.
7. Appleby CE, Ivanov J, Lavi S, Mackie K, Horlick EM, et al. (2009) The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv 2:309-316.
8. Sukhija R, Aronow WS, Palaniswamy C, Singh T, Sukhija R, et al. (2010) Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents. Am J Cardiol 105:293-296.
9. Zhang RY, Zhu ZB, Zhang Q, Yang ZK, Hu J, et al. (2009) Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention. Int J Cardiol 136:72-79.
10. Nutritional anaemias. Report of a WHO scientific group (1968). World Health Organ Tech Rep Ser 405:5-37.
11. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
12. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, et al. (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736-2747.
13. Duncan T (2004) Statistical Methods in Genetic Epidemiology. 1 edition. Oxford; New York: Oxford University Press. 464 p.
14. Richardson DB, Kaufman JS (2009) Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol 169:756-760.
15. Rothman KJ, Professor TLLA, Greenland S (2012) Modern Epidemiology. Third, Mid-cycle revision edition. Philadelphia: LWW. 758 p.
16. Moore RA, Derry CJ, Derry S, Straube S, McQuay HJ (2012) A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine. Eur J Pain Lond Engl 16:585-591.
17. De Wreede LC, Fiocco M, Putter H (2010) The mstate package for estimation and prediction in nonand semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed 99:261-274.
18. Putter H, Fiocco M, Geskus RB (2007) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26:2389-2430.
19. Pilgrim T, Vetterli F, Kalesan B, Stefanini GG, Räber L, et al. (2012) The impact of anemia on longterm clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv 5:202-210.